This Medicines Q&A evaluates the evidence for using low molecular weight heparins for the prevention of travel-related venous thromboembolism
Attachments
- UKMI_QA_LMWH_prior_to_travel_Sep18_Final · Word · 136 KB
This Medicines Q&A evaluates the evidence for using low molecular weight heparins for the prevention of travel-related venous thromboembolism